ArticleJTO clinical and research reports2024

Rapid Response to Lenvatinib and Disease Flare After Discontinuation in a Patient With Thymic Carcinoma Harboring KIT Exon 11 Mutation: A Case Report.

Masahiro Torasawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.